Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in China

被引:1
|
作者
Hang, Dong [1 ,2 ]
Sun, Dianjianyi [3 ,4 ,5 ]
Du, Lingbin [6 ,7 ]
Huang, Jianv [1 ]
Li, Jiacong [1 ]
Zhu, Chen [1 ,6 ]
Wang, Le [6 ]
He, Jingjing [1 ]
Zhu, Xia [1 ]
Zhu, Meng [1 ,2 ]
Song, Ci [1 ,2 ]
Dai, Juncheng [1 ,2 ]
Yu, Canqing [3 ,4 ,5 ]
Xu, Zekuan [8 ]
Li, Ni [9 ]
Ma, Hongxia [1 ,2 ]
Jin, Guangfu
Yang, Ling [10 ,11 ,12 ]
Chen, Yiping [10 ,11 ,12 ]
Du, Huaidong [10 ,11 ,12 ]
Cheng, Xiangdong [6 ,7 ]
Chen, Zhengming [11 ]
Lv, Jun [3 ,4 ,5 ,6 ]
Hu, Zhibin [1 ,2 ]
Li, Liming [3 ,4 ,5 ]
Shen, Hongbing [1 ,2 ,13 ]
机构
[1] Nanjing Med Univ, Ctr Global Hlth, Sch Publ Hlth, Dept Epidemiol, Nanjing, Peoples R China
[2] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, China Int Cooperat Ctr Environm & Human Hlth, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, 38 Xueyuan Rd, Beijing 100191, Peoples R China
[4] Peking Univ, Ctr Publ Hlth & Epidem Preparedness & Response, Beijing, Peoples R China
[5] Peking Univ, Key Lab Epidemiol Major Dis, Minist Educ, Beijing, Peoples R China
[6] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Canc Hosp, Dept Canc Prevent, Hangzhou, Peoples R China
[7] Chinese Acad Sci, Inst Basic Med & Canc IBMC, Hangzhou, Peoples R China
[8] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China
[9] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp,Off Canc Screening, Beijing, Peoples R China
[10] Univ Oxford, Med Res Council, Populat Hlth Res Unit, Oxford, England
[11] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England
[12] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England
[13] Chinese Acad Med Sci, Res Units Cohort Study Cardiovasc Dis & Canc, Beijing, Peoples R China
基金
中国国家自然科学基金; 英国惠康基金;
关键词
Colorectal cancer; Risk prediction; Screening; Cohort study; ADVANCED NEOPLASIA; GALLSTONE DISEASE; VALIDATION; ASSOCIATION; KADOORIE; BIOBANK; TRENDS; MODEL; RULE;
D O I
10.1016/j.canlet.2024.217057
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Risk prediction tools for colorectal cancer (CRC) have potential to improve the efficiency of population-based screening by facilitating risk-adapted strategies. However, such an applicable tool has yet to be established in the Chinese population. In this study, a risk score was created using data from the China Kadoorie Biobank (CKB), a nationwide cohort study of 409,854 eligible participants. Diagnostic performance of the risk score was evaluated in an independent CRC screening programme, which included 91,575 participants who accepted colonoscopy at designed hospitals in Zhejiang Province, China. Over a median follow-up of 11.1 years, 3136 CRC cases were documented in the CKB. A risk score was created based on nine questionnaire-derived variables, showing moderate discrimination for 10-year CRC risk (C-statistic = 0.68, 95 % CI: 0.67-0.69). In the CRC screening programme, the detection rates of CRC were 0.25 %, 0.82 %, and 1.93 % in low-risk (score <6), intermediate-risk (score: 6-19), and high-risk (score >19) groups, respectively. The newly developed score exhibited a C-statistic of 0.65 (95 % CI: 0.63-0.66), surpassing the widely adopted tools such as the Asia-Pacific Colorectal Screening (APCS), modified APCS, and Korean Colorectal Screening scores (all C-statistics = 0.60). In conclusion, we developed a novel risk prediction tool that is useful to identify individuals at high risk of CRC. A user-friendly online calculator was also constructed to encourage broader adoption of the tool.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Head-to-head comparison of a risk-adapted screening strategy using various risk prediction models in detecting colorectal neoplasm
    Lu, Ming
    Zhang, Yuhan
    Cai, Jie
    Lu, Bin
    Luo, Chenyu
    Chen, Hongda
    Dai, Min
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 (07) : 1244 - 1252
  • [22] Beyond familial risk: deriving risk-adapted starting ages of screening among people with a family history of colorectal cancer
    Chen, Xuechen
    Heisser, Thomas
    Cardoso, Rafael
    Hibbert, Julia
    Hoffmeister, Michael
    Brenner, Hermann
    CANCER COMMUNICATIONS, 2023, 43 (12) : 1377 - 1380
  • [23] Risk-adapted PSA screening - a way to reduce the harms of prostate cancer screening
    Recker, F.
    Randazzo, M.
    Wyler, S. F.
    Huber, A.
    Grobholz, R.
    Manka, L.
    Kwiatkowski, M.
    Oncology Research and Treatment, 2015, 38 : 109 - 110
  • [24] Risk-adapted PSA screening and the PROBASE trial
    Arsov, C.
    Becker, N.
    Albers, P.
    ONKOLOGE, 2015, 21 (09): : 778 - +
  • [25] Risk-adapted prevention of the breast cancer
    Schmutzler, Rita
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2009, 59 (11): : 595 - 596
  • [26] RISK-ADAPTED THERAPY FOR CANCER OF THE ENDOMETRIUM
    BENDER, HG
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1993, 49 (1-2): : 50 - 50
  • [27] Determining the Appropriate Risk-Adapted Screening Age for Familial Breast Cancer
    Hemminki, Kari
    JAMA ONCOLOGY, 2020, 6 (06) : 933 - +
  • [28] Risk-adapted cancer screening-what are the consequences for those affected?
    Schilling, D.
    GASTROENTEROLOGE, 2019, 14 (01): : 24 - 29
  • [29] Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer
    Mukama, Trasias
    Kharazmi, Elham
    Xu, Xing
    Sundquist, Kristina
    Sundquist, Jan
    Brenner, Hermann
    Fallah, Mahdi
    JAMA ONCOLOGY, 2020, 6 (01) : 68 - 74
  • [30] Validation of RiskCheck Bladder Cancer©, Version 5.0 for Risk-Adapted Screening of Bladder Cancer
    Martini, T.
    Mayr, R.
    Lodde, M.
    Seitz, C.
    Trenti, E.
    Comploj, E.
    Palermo, S.
    Pycha, A.
    Mian, C.
    Zywica, M.
    Weidner, W.
    Luedecke, G.
    UROLOGIA INTERNATIONALIS, 2013, 91 (02) : 175 - 181